Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 271-279 , February 2007

Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation

  • Peter F. Mount

      Affiliations

    • Department of Nephrology, Austin Health, Studley Road, Heidelberg 3084, Victoria, Australia
    • Burnet Institute, Austin Health, Studley Road, Heidelberg 3084, Victoria, Australia
    • Corresponding Author InformationCorresponding author. The Northern Hospital, 185 Cooper St, Epping, 3076 Victoria, Australia. Tel.: +61 613 84052024; fax: +61 613 98590490.
    • ,
  • Bruce E. Kemp

      Affiliations

    • St. Vincent's Institute, Fitzroy 3065, Victoria, Australia
    • CSIRO Health Sciences and Nutrition, Parkville, Victoria, Australia
    • ,
  • David A. Power

      Affiliations

    • Department of Nephrology, Austin Health, Studley Road, Heidelberg 3084, Victoria, Australia
    • Burnet Institute, Austin Health, Studley Road, Heidelberg 3084, Victoria, Australia

Received 1 February 2006 ,Revised 3 May 2006 ,Accepted 31 May 2006.

References 

  1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288(5789):373–376
  2. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327(6122):524–526
  3. Marsh N, Marsh A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol. 2000;27(4):313–319
  4. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta, Bioenerg. 1999;1411(2–3):217–230
  5. Bredt DS, Snyder S. Isolation of nitric oxide synthatase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990;87:682–685
  6. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res. 1999;43(3):521–531
  7. Kone BC, Kuncewicz T, Zhang W, Yu ZY. Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol Renal Physiol. 2003;285(2):F178–F190
  8. Fulton D, Gratton J-P, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. J Pharmacol Exp Ther. 2001;299(3):818–824
  9. Chen Z-P, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, et al. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett. 1999;443:285–289
  10. Fulton D, Gratton J-P, McCabe TJ, Fontana J, Fujio Y, Franke T, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399:597–601
  11. Bauer PM, Fulton D, Boo YC, Sorescu GP, Kemp BE, Jo H, et al. Compensatory phosphorylation and protein–protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J Biol Chem. 2003;278(17):14841–14849
  12. Michell BJ, Harris MB, Chen ZP, Ju H, Venema VJ, Blackstone MA, et al. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J Biol Chem. 2002;277(44):42344–42351
  13. Matsubara M, Hayashi N, Jing T, Titani K. Regulation of endothelial nitric oxide synthase by protein kinase C. J Biochem (Tokyo). 2003;133(6):773–781
  14. Garcia-Cardena G, Fan R, Stern DF, Liu J, Sessa WC. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem. 1996;271(44):27237–27240
  15. Boo YC, Sorescu G, Boyd N, Shiojima I, Walsh K, Du J, et al. Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A. J Biol Chem. 2002;277(5):3388–3396
  16. Harris MB, Ju H, Venema VJ, Liang H, Zou R, Michell BJ, et al. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem. 2001;276(19):16587–16591
  17. Montagnani M, Chen H, Barr VA, Quon MJ. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser1179. J Biol Chem. 2001;276(32):30392–30398
  18. Harris MB, Blackstone MA, Sood SG, Li C, Goolsby JM, Venema VJ, et al. Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. Am J Physiol, Heart Circ Physiol. 2004;287:H560–H566
  19. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399(6736):601–605
  20. Michell BJ, Griffiths JE, Mitchelhill KI, Rodriguez-Crespo I, Tiganis T, Bozinovski S, et al. The Akt kinase signals directly to endothelial nitric oxide synthase. Current Biology. 1999;9(15):845–848
  21. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R. Phosphorylation of Thr495 regulates Ca2+/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res. 2001;88(11):68–75
  22. Butt E, Bernhardt M, Smolenski A, Kotsonis P, Frohlich LG, Sickmann A, et al. Endothelial nitric-oxide synthase (Type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem. 2000;275(7):5179–5187
  23. Michell BJ, Chen Z-p, Tiganis T, Stapleton D, Katsis F, Power DA, et al. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem. 2001;276(21):17625–17628
  24. Lane P, Gross SS. Disabling a C-terminal autoinhibitory control element in endothelial nitric-oxide synthase by phosphorylation provides a molecular explanation for activation of vascular NO synthesis by diverse physiological stimuli. J Biol Chem. 2002;277(21):19087–19094
  25. Greif DM, Kou R, Michel T. Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: evidence for crosstalk between phosphorylation sites. Biochemistry. 2002;41(52):15845–15853
  26. Lin MI, Fulton D, Babbitt R, Flemming I, Busse R, Pritchard KA, et al. Phosphorylation of threonine 497 in endothelial nitric oxide synthase coordinates the coupling of l-arginine metabolism to efficient nitric oxide production. J Biol Chem. 2003;278:44719–447126
  27. Thomas SR, Chen K, Keaney JF. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem. 2002;277(8):6017–6024
  28. Munzel T, Daiber A, Ullrich V, Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol. 2005;25(8):1551–1557
  29. Boo YC, Hwang J, Sykes M, Michell BJ, Kemp BE, Lum H, et al. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am J Physiol, Heart Circ Physiol. 2002;283(5):H1819–H1828
  30. Boo YC, Sorescu GP, Bauer PM, Fulton D, Kemp BE, Harrison DG, et al. Endothelial NO synthase phosphorylated at SER635 produces NO without requiring intracellular calcium increase. Free Radic Biol Med. 2003;35(7):729–741
  31. Kou R, Greif D, Michel T. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem. 2002;277(33):29669–29673
  32. Cho DH, Choi YJ, Jo SA, Jo I. Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways. J Biol Chem. 2004;279(4):2499–2506
  33. Gallis B, Corthals GL, Goodlett DR, Ueba H, Kim F, Presnell SR, et al. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem. 1999;274(42):30101–30108
  34. Drew BG, Fidge NH, Gallon-Beaumier G, Kemp BE, Kingwell BA. High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci U S A. 2004;101(18):6999–7004
  35. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Medicine (Maywood). 2003;228(2):111–133
  36. Brouet A, Sonveaux P, Dessy C, Balligand JL, Feron O. Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J Biol Chem. 2001;276(35):32663–32669
  37. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N, et al. Domain mapping studies reveal that the m domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res. 2002;90(8):866–87310.1161/01.RES.0000016837.26733.BE
  38. Takahashi S, Mendelsohn ME. Synergistic activation of endothelial nitric-oxide synthase (eNOS) by HSP90 and Akt: calcium-independent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex. J Biol Chem. 2003;278(33):30821–30827
  39. Kupatt C, Dessy C, Hinkel R, Raake P, Daneau G, Bouzin C, et al. Heat shock protein 90 transfection reduces ischemia–reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase Serine 1177 phosphorylation and Threonine 495 dephosphorylation. Arterioscler Thromb Vasc Biol. 2004;24(8):1435–144110.1161/01.ATV.0000134300.87476.d1
  40. Wei Q, Xia Y. Roles of 3-phosphoinositide-dependent kinase 1 in the regulation of endothelial nitric-oxide synthase phosphorylation and function by heat shock protein 90. J Biol Chem. 2005;280(18):18081–1808610.1074/jbc.M413607200
  41. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 1998;392(6678):821–824
  42. Shaul PW. Regulation Of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol. 2002;64(1):749–774
  43. Venema RC. Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin. Int Immunopharmacol. 2002;2(13–14):1755–1762
  44. Forstermann U, Pollock JS, Schmidt HH, Heller M, Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1991;88(5):1788–1792
  45. Michel JB, Feron O, Sase K, Prabhakar P, Michel T. Caveolin versus calmodulin. counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem. 1997;272(41):25907–25912
  46. Ju H, Venema VJ, Marrero MB, Venema RC. Inhibitory interactions of the bradykinin b2 receptor with endothelial nitric-oxide synthase. J Biol Chem. 1998;273(37):24025–24029
  47. Sun J, Liao JK. Functional interaction of endothelial nitric oxide synthase with a voltage-dependent anion channel. Proc Natl Acad Sci U S A. 2002;99:13108–13113
  48. Harris MB, Ju H, Venema VJ, Blackstone M, Venema RC. Role of heat shock protein 90 in bradykinin-stimulated endothelial nitric oxide release. Gen Pharmacol. 2000;35(3):165–170
  49. Bae SW, Kim HS, Cha YN, Park YS, Jo SA, Jo I. Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway. Biochem Biophys Res Commun. 2003;306(4):981–987
  50. Prabhakar P, Thatte HS, Goetz RM, Cho MR, Golan DE, Michel T. Receptor-regulated translocation of endothelial nitric-oxide synthase. J Biol Chem. 1998;273(42):27383–27388
  51. Gelinas DS, Bernatchez PN, Rollin S, Bazan NG, Sirois MG. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. Br J Pharmacol. 2002;137(7):1021–1030
  52. Igarashi J, Thatte HS, Prabhakar P, Golan DE, Michel T. Calcium-independent activation of endothelial nitric oxide synthase by ceramide. Proc Natl Acad Sci U S A. 1999;96(22):12583–12588
  53. Thors B, Halldorsson H, Thorgeirsson G. Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt. FEBS Lett. 2004;573(1–3):175–180
  54. Massion PB, Pelat M, Belge C, Balligand J-L. Regulation of the mammalian heart function by nitric oxide. Comp Biochem Physiol, Part A Mol Integr Physiol. 2005;142(2):144–150[Papers from: Nitric Oxide: Comparative Aspects of Respiratory and Cardiovascular Homeostasis, an SEB symposium, organised by Prof. Bruno Tota (University of Calabria, Italy) and Prof. Tobias Wang (University of Aarhus, Denmark)—Capri, Italy, September 2004]
  55. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 1996;271(37):22810–2281410.1074/jbc.271.37.22810
  56. Lin C-S, Lau A, Bakircioglu E, Tu R, Wu F, Week S. Analysis of neuronal nitric oxide synthase isoform expression and identification of human nNOS-[mu]. Biochem Biophys Res Commun. 1998;253(2):388–394
  57. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93(6):1087–1094
  58. Gao F, Gao E, Yue T-L, Ohlstein EH, Lopez BL, Christopher TA, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia–reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation. 2002;105(12):1497–150210.1161/01.CIR.0000012529.00367.0F
  59. Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2002;8(5):473–479
  60. Bell RM, Yellon DM. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J Mol Cell Cardiol. 2003;35(2):185–193
  61. Wang Y, Ahmad N, Kudo M, Ashraf M. Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning. Am J Physiol, Heart Circ Physiol. 2004;287(3):H1125–H113110.1152/ajpheart.00183.2004
  62. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-akt pathway. Circ Res. 2004;95(3):230–23210.1161/01.RES.0000138303.76488.fe
  63. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 2004;24(10):1842–184710.1161/01.ATV.0000142813.33538.82
  64. Birnbaum Y, Ye Y, Rosanio S, Tavackoli S, Hu Z-Y, Schwarz ER, et al. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia–reperfusion injury. Cardiovasc Res. 2005;65(2):345–355
  65. Sasso FC, Torella D, Carbonara O, Ellison GM, Torella M, Scardone M, et al. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. J Am Coll Cardiol. 2005;46(5):827–834
  66. Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Shintani Y, et al. Celiprolol, a vasodilatory {beta}-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Circulation. 2004;110(6):692–69910.1161/01.CIR.0000137831.08683.E1
  67. Kobayashi N, Yoshida K, Nakano S, Ohno T, Honda T, Tsubokou Y, et al. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension. 2006;47(4):671–67910.1161/01.HYP.0000203148.42892.7a
  68. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003;278:45021–45026
  69. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem. 2004;279(2):1304–1309
  70. Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 2002;51(1):168–173
  71. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-akt pathway in human endothelial cells. Circ Res. 2000;87(8):677–682

PII: S0022-2828(06)00588-8

doi: 10.1016/j.yjmcc.2006.05.023

Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 271-279 , February 2007

Article Tools

* Image Usage & Resolution